株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の等温核酸増幅技術 (INAAT) 市場:製品タイプ、技術、用途、エンドユーザー、地域別 - 規模、シェア、動向、および予測

Isothermal Nucleic Acid Amplification Technology Market, by Product Type, by Technology, by Application, by End User, and by Region - Size, Share, Trends, and Forecast 2018 - 2026

発行 Coherent Market Insights 商品コード 906221
出版日 ページ情報 英文 177 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
世界の等温核酸増幅技術 (INAAT) 市場:製品タイプ、技術、用途、エンドユーザー、地域別 - 規模、シェア、動向、および予測 Isothermal Nucleic Acid Amplification Technology Market, by Product Type, by Technology, by Application, by End User, and by Region - Size, Share, Trends, and Forecast 2018 - 2026
出版日: 2019年07月16日 ページ情報: 英文 177 Pages
概要

当レポートは世界の等温核酸増幅技術 (INAAT) 市場について調査しており、市場の機会、動向や影響、成長および阻害要因、製品タイプ・技術・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査の目的および仮定

  • 調査目的
  • 仮定
  • 略語

第2章 市場の概要

  • レポートの説明
    • 市場の定義および範囲
  • エグゼクティブサマリー
    • 製品タイプ別
    • 技術別
    • 用途別
    • エンドユーザー別
    • 地域別
  • COM (Coherent Opportunity Map)

第3章 市場力学、規制、動向分析

  • 市場力学
    • 成長要因
    • 阻害要因
    • 市場機会
  • 影響分析
  • 市場動向
  • 主な開発
  • 技術の進歩
  • 歴史的概要
  • 合併および買収
  • 規制シナリオ
  • ポーターのファイブフォース分析
  • PEST分析

第4章 等温核酸増幅技術 (INAAT) の世界市場:製品タイプ別の予測

  • イントロダクション
  • 機器
  • 試薬

第5章 等温核酸増幅技術 (INAAT) の世界市場:技術別の予測

  • イントロダクション
  • ヘリカーゼ依存性増幅(HAD)
  • ニック酵素増幅反応(NEAR)
  • 核酸配列ベースの増幅(NASBA)
  • 転写薬用増幅(TMA)
  • シングルプライマー等温増幅(SPIA)
  • ループ媒介等温増幅(LAMP)

第6章 等温核酸増幅技術 (INAAT) の世界市場:用途別の予測

  • イントロダクション
  • 血液スクリーニング
  • 腫瘍学
  • 研究開発活動
  • その他

第7章 等温核酸増幅技術 (INAAT) の世界市場:エンドユーザー別の予測

  • イントロダクション
  • 学術研究機関
  • 診断研究所
  • その他

第8章 等温核酸増幅技術 (INAAT) の世界市場:地域別の予測

  • イントロダクション
    • 市場シェア分析
    • 前年比成長分析
    • 地域動向
  • 北米
    • 市場規模および予測:製品タイプ別
    • 市場規模および予測:技術別
    • 市場規模および予測:用途別
    • 市場規模および予測:エンドユーザー別
    • 市場規模および予測:国別
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • フランス
    • スペイン
    • ロシア
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • ASEAN
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他
  • アフリカ
    • 北アフリカ
    • 中央アフリカ
    • 南アフリカ
  • 中東
    • GCC諸国
    • イスラエル
    • その他

第9章 競合情勢

  • ヒートマップ分析
  • 企業プロファイル
    • Alere, Inc.
    • Becton, Dickinson & Company
    • BioHelix Corporation
    • BioMerieux Biotechnology Company
    • Hologic Gene-Probe
    • QIAGEN Company
    • Thermo Fisher Scientific
    • Lucigen Corporation
    • Quidel Corporation
    • NuGEN
  • アナリストビュー

第10章 セクション

  • 参照資料
  • 調査方法
  • Coherent Market Insightについて
目次

Title:
Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents), by Technology (Helicase Dependent Amplification (HAD), Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence Based Amplification (NASBNA), Transcription medicated amplification (TMA), Single primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), by Application (Blood Screening, Oncology, Research and Development activities, and Others), by End User (Academic and Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026.

Isothermal nucleic acid technologies are used in recombinant DNA and molecular biology techniques. These techniques are used in detection and analysis of a small quantity of nucleic acids. Polymerases chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists a thermocycling machine, which facilitates separation and amplification of DNA strands.

Market Dynamics:

Increasing approvals from healthcare regulatory authorities for innovative technologies is expected to drive the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in October 2018, Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.

Furthermore, rising product launches by key players is expected to boost the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in July 2017, TwistDx Inc. launched TwistAmp, a recombinase polymerase amplification (RPA) kit. It is used for DNA/RNA amplification. TwistAmp is an isothermal alternative to polymerase chain reaction PCR.

Key features of the study:

  • This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period (2018-2026), considering 2017, as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include, Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type:
    • Instruments
    • Reagents
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology:
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market , By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Product Type:
    • Instruments
    • Reagents
      • By Technology:
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
      • By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
      • By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Product Type:
    • Instruments
    • Reagents
      • By Technology:
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
      • By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
      • By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Product Type:
    • Instruments
    • Reagents
      • By Technology
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
      • By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
      • By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Product Type:
    • Instruments
    • Reagents
      • By Technology:
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
      • By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
      • By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
    • Middle East
      • By Country:
    • GCC Countries
    • Israel
    • Rest of Middle East
      • By Product Type:
    • Instruments
    • Reagents
      • By Technology:
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
      • By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
      • By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
      • By Product Type:
    • Instruments
    • Reagents
      • By Technology:
    • Helicase Dependent Amplification (HAD)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Nucleic Acid Sequence Based Amplification (NASBA)
    • Transcription Medicated Amplification (TMA)
    • Single Primer Isothermal Amplification (SPIA)
    • Loop-mediated Isothermal Amplification (LAMP)
      • By Application:
    • Blood Screening
    • Oncology
    • Research and Development Activities
    • Others
      • By End User Type:
    • Academic and Research Institutes
    • Diagnostic Laboratories
    • Others
  • Company Profiles
    • Alere Inc.,*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Becton, Dickinson & Company
    • BioHelix Corporation
    • BioMerieux Biotechnology Company
    • Hologic Gene-Probe
    • QIAGEN Company
    • Thermo Fisher Scientific, Inc.
    • Lucigen Corporation
    • Quidel Corporation
    • NuGEN

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Helicase Dependent Amplification (HAD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Nicking Enzyme Amplification Reaction (NEAR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Nucleic Acid Sequence Based Amplification (NASBA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Transcription Medicated Amplification (TMA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Single Primer Isothermal Amplification (SPIA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Loop-mediated Isothermal Amplification (LAMP)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Blood Screening
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Research and Development Activities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market By End User, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

8. Global, Isothermal Nucleic Acid Amplification Technology (INAAT) Market By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application , 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Technology , 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Japan
    • China
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million
    • Market Size and Forecast, By Country/Region, 2016 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Alere, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Becton, Dickinson & Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioHelix Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioMerieux Biotechnology Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Hologic Gene-Probe
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • QIAGEN Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Lucigen Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Quidel Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • NuGEN
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top